Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans

Journal of Pathology

Volumn 223, Issue 3, 2011, Pages 425-435

  Bellemare, Judith ^a   Rouleau, Mélanie ^a   Harvey, Mario ^a   Popa, Ion ^b   Pelletier, Georges ^b   Têtu, Bernard ^b   Guillemette, Chantal ^a  

^a Université Laval   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Dominant negative function; Human tissues; Metabolism; Splice variants; UDP glucuronosyltransferase (UGT)

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 1AI1; GLUCURONOSYLTRANSFERASE 1AI2; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; COLON; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN VITRO STUDY; INTESTINE; KIDNEY; LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; STOMACH;

ALTERNATIVE SPLICING; COLONIC NEOPLASMS; GLUCURONOSYLTRANSFERASE; HUMANS; INTESTINE, SMALL; ISOENZYMES; KIDNEY; LIVER NEOPLASMS; STOMACH;

EID: 78650592884     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2805     Document Type: Article

References (33)

1. Girard H, Thibaudeau J, Court MH, et al., UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver. Hepatology 2005; 42: 448-457. (Pubitemid 41061098)
2. Girard H, Levesque E, Bellemare J, et al., Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genom 2007; 17: 1077-1089. (Pubitemid 351339492)
3. Levesque E, Girard H, Journault K, et al., Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 2007; 45: 128-138. (Pubitemid 46144372)
4. Bellemare J, Rouleau M, Harvey M, et al., Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines. Pharmacogenom J 2010; 10: 431-441.
5. Gaganis P, Miners JO, Brennan JS, et al., Human renal cortical and medullary UDP-glucuronosyltransferases (UGTs): immunohistochemical localization of UGT2B7 and UGT1A enzymes and kinetic characterization of S-naproxen glucuronidation. J Pharmacol Exp Ther 2007; 323: 422-430. (Pubitemid 350005128)
6. Girard C, Barbier O, Veilleux G, et al., Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology 2003; 144: 2659-2668. (Pubitemid 36629919)
7. Giuliani L, Ciotti M, Stoppacciaro A, et al., UDP- glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry. Oncol Rep 2005; 13: 185-191.
8. Knapp SA, Green MD, Tephly TR, et al., Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats. Mol Pharmacol 1988; 33: 14-21.
9. Peters WH, Jansen PL, Nauta H,. The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase. J Biol Chem 1984; 259: 11701-11705. (Pubitemid 14022088)
10. Caceres JF, Kornblihtt AR,. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 2002; 18: 186-193.
11. Pettigrew CA, Brown MA,. Pre-mRNA splicing aberrations and cancer. Front Biosci 2008; 13: 1090-1105.
12. Albert C, Vallee M, Beaudry G, et al., The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes. Endocrinology 1999; 140: 3292-3302. (Pubitemid 30650648)
13. Duguay Y, McGrath M, Lepine J, et al., The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res 2004; 64: 1202-1207. (Pubitemid 38176930)
14. Thibaudeau J, Lepine J, Tojcic J, et al., Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res 2006; 66: 125-133. (Pubitemid 43166017)
15. Roberts RA, Ganey PE, Ju C, et al., Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 2007; 96: 2-15. (Pubitemid 46323203)
16. Gregory SH, Wing EJ,. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 2002; 72: 239-248.
17. Neyrinck AM, Alexiou H, Delzenne NM,. Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endotoxic shock. J Nutr 2004; 134: 1124-1129. (Pubitemid 38619950)
18. Neyrinck A,. Modulation of Kupffer cell activity: physio-pathological consequences on hepatic metabolism. Bull Mem Acad R Med Belg 2004; 159: 358-366.
19. Knights KM, Miners JO,. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Drug Metab Rev 2010; 42: 60-70.
20. Seliskar M, Rozman D,. Mammalian cytochromes P450 - importance of tissue specificity. Biochim Biophys Acta 2007; 1770: 458-466. (Pubitemid 46136750)
21. Peters WH, Allebes WA, Jansen PL, et al., Characterization and tissue specificity of a monoclonal antibody against human uridine 5′-diphosphate- glucuronosyltransferase. Gastroenterology 1987; 93: 162-169. (Pubitemid 17084109)
22. Bonvalet JP, Pradelles P, Farman N,. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 1987; 253: F377-387. (Pubitemid 18073133)
23. Hao CM, Breyer MD,. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int 2007; 71: 1105-1115.
24. Turgeon D, Chouinard S, Belanger P, et al., Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J Lipid Res 2003; 44: 1182-1191. (Pubitemid 37279636)
25. Hanninen O, Lindstrom-Seppa P, Pelkonen K,. Role of gut in xenobiotic metabolism. Arch Toxicol 1987; 60: 34-36. (Pubitemid 17081680)
26. Radominska-Pandya A, Little JM, Pandya JT, et al., UDP- glucuronosyltransferases in human intestinal mucosa. Biochim Biophys Acta 1998; 1394: 199-208. (Pubitemid 28495654)
27. Strassburg CP, Nguyen N, Manns MP, et al., UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 1999; 116: 149-160. (Pubitemid 29013504)
28. Bellemare J, Rouleau M, Girard H, et al., Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos 2010; (in press).
29. Bellemare J, Rouleau M, Harvey M, et al., Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions. J Biol Chem 2010; 285: 3600-3607.
30. Fremont JJ, Wang RW, King CD,. Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. Mol Pharmacol 2005; 67: 260-262. (Pubitemid 40069986)
31. Ganz T,. Paneth cells - guardians of the gut cell hatchery. Nat Immunol 2000; 1: 99-100.
32. Strassburg CP, Manns MP, Tukey RH,. Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res 1997; 57: 2979-2985.
33. Lepine J, Bernard O, Plante M, et al., Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 2004; 89: 5222-5232. (Pubitemid 39391472)